Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

STAAR Surgical Company

STAA
Current price
26.66 USD -0.91 USD (-3.30%)
Last closed 27.3 USD
ISIN US8523123052
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 1 458 073 856 USD
Yield for 12 month -24.39 %
1Y
3Y
5Y
10Y
15Y
STAA
21.11.2021 - 28.11.2021

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California. Address: 25651 Atlantic Ocean Drive, Lake Forest, CA, United States, 92630

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

44.07 USD

P/E ratio

67.25

Dividend Yield

Current Year

+322 415 000 USD

Last Year

+284 391 000 USD

Current Quarter

+88 590 000 USD

Last Quarter

+99 005 000 USD

Current Year

+252 651 000 USD

Last Year

+223 383 000 USD

Current Quarter

+68 487 000 USD

Last Quarter

+78 412 000 USD

Key Figures STAA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 33 086 000 USD
Operating Margin TTM 6.49 %
PE Ratio 67.25
Return On Assets TTM 3.39 %
PEG Ratio -4.89
Return On Equity TTM 5.4 %
Wall Street Target Price 44.07 USD
Revenue TTM 341 224 000 USD
Book Value 8.69 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 10.3 %
Dividend Yield
Gross Profit TTM 223 383 000 USD
Earnings per share 0.44 USD
Diluted Eps TTM 0.44 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY 101.8 %
Profit Margin 6.38 %

Dividend Analytics STAA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History STAA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:2
Payout Ratio
Last Split Date 18.05.1992
Dividend Date

Stock Valuation STAA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 67.25
Forward PE 227.2727
Enterprise Value Revenue 3.6988
Price Sales TTM 4.2731
Enterprise Value EBITDA 40.1538
Price Book MRQ 3.4057

Financials STAA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators STAA

For 52 weeks

26.66 USD 52.68 USD
50 Day MA 31.64 USD
Shares Short Prior Month 5 058 411
200 Day MA 37.62 USD
Short Ratio 4.61
Shares Short 4 180 753
Short Percent 16.91 %